Influence of apoA-V gene variants on postprandial triglyceride metabolism: Impact of gender

Journal of Lipid Research

Volumn 49, Issue 5, 2008, Pages 945-953

  Olano Martin, Estibaliz ^a   Abraham, Elizheeba C ^a   Gill Garrison, Rosalynn ^b   Valdes, Ana M ^b,c   Grimaldi, Keith ^b   Tang, Fiona ^a   Jackson, Kim G ^a   Williams, Christine M ^a   Minihane, Anne M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b Sciona Inc   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Apolipoprotein A V apoA1 C3 A4 A5 gene locus; Polymorphism; Postprandial lipemia

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; FATTY ACID;

ADULT; AGED; CONFERENCE PAPER; DIET RESTRICTION; FEMALE; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; LIPID METABOLISM; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; WILD TYPE; ARTICLE; BLOOD; GENETICS; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADULT; AGED; APOLIPOPROTEINS A; FATTY ACIDS, NONESTERIFIED; FEMALE; GENOTYPE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTPRANDIAL PERIOD; SEX CHARACTERISTICS; TRIGLYCERIDES; VARIATION (GENETICS);

EID: 49849088496     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700112-JLR200     Document Type: Conference Paper

References (50)

1. Pennacchio, L. A., M. Olivier,J. A. Hubacek, J. C. Cohen, D. R. Cox, J. C. Fruchart, R. M. Krauss, and E. M. Rubin. 2001. An apolipo- protein influencing triglycerides in humans and mice revealed by sequencing. Science. 294: 169-173.
2. Olofsson, S. O. 2005. Apo A-V: the regulation of a regulator of plasma triglycerides. Arterioscler. Thromb. Vasc. Biol. 25: 1097-1099.
3. Weinberg, R. B., V. R. Cook, J. A. Beckstead, D. D. O. Martin, J. W. Gallagher, G. S. Shelness, and R. O. Ryan. 2003. Structure and interfacial properties of human apolipoprotein A-V. J. Biol. Chem. 278: 34438-34444.
4. Jackel, H., M. Nowak, A. Helleboid-Chapman, J. Fruchart-Najib, and J. C. Fruchart. 2006. Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins? Ann. Med. 38: 2-10.
5. Schaap, F. G., P. C. N. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. F. M. Chamuleua, L. M. Havekes, A. K. Groen and K. W. van Dijk. 2004. ApoA5 reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947.
6. Merkel, M., B. Loeffler, M. Kluger, M. N. Fabig, G. Geppert, L. A. Pennacchio, A. Laatsch, and J. Heeren. 2005. Apolipoprotein A5 accelerates plasma hydrolysis of triglyceride rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J. Biol. Chem. 280: 21553-21560.
7. Pennacchio, L. A., and E. M. Rubin. 2003. Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler. Thromb. Vasc. Biol. 23: 529-534.
8. Endo, K., H. Yanagi, J. Araki, C. Hirano, K. Yamakawa-Kobayashi, and S. Tomura. 2002. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and serum triglyceride in Japanese school children. Hum. Genet. 111: 570-572.
9. Dallongivelle, J., D. Cottel, M. Montaye, V. Codron, P. Amouyel, and N. Helbecque. 2006. Impact of apoA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int. J. Cardiol. 106: 152-156.
10. Hsu, L-A., Y-L. Ko, C-J. Chang, C-F. Hu, S. Wu, M-S. Teng, C-L. Wang, W-J. Ho, Y-S. Ko, T-S. Hsu, et al. 2006. Genetic variations of apolipoprotein a5 gene is associated with the risk ofcoronary artery disease among Chinese in Taiwan. Atherosclerosis. l85: 143-149.
11. Bi, N., S-K Yan, G-P. Li, Z-N. Yin, and B-S. Chen. 2004. A single nucleotide polymorphism -1131 T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary heart disease and alters triglyceride metabolism in Chinese. Mol. Genet. Metab. 83:280-286.
12. Szalai, C., M. Kesei, J. Duba, M. Keszei,J. Duba, Z. Prohasszka, G. T. Kozma, A. Csaszar, S. Balogh, Z. Almassy, et al. 2004. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary heart disease. Atherosclerosis. 173: 109-114.
13. Talmud, P. J., S. Martin, M. R. Taskinen, M. H. Frick, M. S. Nieminen, Y. A. Kesaniemi, A. Pasternack, S. E. Humphries, and M. Syvanne. 2004. ApoA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT Study. J. Lipid Res. 45: 750-756.
14. Elosua, R., J. M. Ordovas, L. A. Cupples, C-Q. Lai, S. Demissie, C. S. Fox, J. F. Polak, P. A. Wolf, R. B. D'Agostino, and C.J. O'Donnell. 2006. Variants at the apoA-V locus, association with carotid atherosclerosis, and a modification by obesity: the Framingham Study. J. Lipid Res. 47: 990-996.
15. Yamada, Y., K. Kato, T. Hibino, K. Yokoi, H. Matsuo, T. Segawa, S. Watanabe, S. Ichihara, H. Yoshida, K. Satoh, et al. 2007. Prediction of genetic risk for metabolic syndrome. Atherosclerosis. l9l:298-304.
16. Ribalta, J., L. Figuera, J. Fernandez-Ballart, E. Vilella, M. Castro Cabezas, L. Masana, and J. Joven. 2002. Newly identified apolipo-protein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidaemia. Clin. Chem. 48: 1597-1600.
17. Eichenbaum-Voline, S., M. Olivier, E. L. Jones, R. P. Naoumova, B. Jones, B. Gau, H. N. Patel, M. Seed, D. J. Betteridge, D. J. Galton, et al. 2004. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyper-lipidemia. Arterioscler. Thromb. Vasc. Biol. 24: 167-174.
18. Mar, R., P. Pajukanta, H. Allayee, M. Groenendijk, G. Dallinga- Thie, R. M. Krauss, J. S. Sinsheimer, R. M. Cantor, T. W. de Bruin, and A. J. Lusis. 2004. Association of the APOLIPOPROTEIN A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ. Res. 94: 993-999.
19. Naukkarinen, J., C. Ehnholm, and L. Peltonen. 2006. Genetics of familial combined hyperlipidemia. Curr. Opin. Lipidol. l7: 285-290.
20. van der Vleuten, G. M., A. Isaacs, W. W. Zeng, E. ter Avest, P. J. Talmud, G. M. Dallinga-Thie, C. M. van Duijn, A. F. Stalenhoef, and J. de Graaf. 2007. Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. Biochim. Biophys. Acta. 1772: 81-88.
21. Pennacchio, L. A., M. Olivier, J. S. Hubacek, R. M. Kruass, E. M. Rubin, and J. C. Cohen. 2002. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum. Mol. Genet. 11: 3031-3038.
22. Henneman, P., F. G. Schaap, L. M. Havekes, P. C. N. Rensen, R. R. Frants, A. van Tol, H. Hatori, A. H. M. Smelt, and K. W. van Dijk. 2007. Plasma apoAV levels are markedly elevated in severe hyper-triglyceridemia and positively correlated with the apoA-V S19W polymorphism. Atherosclerosis. 193: 129-134.
23. Hodoglugil, U., S. Tanyolac, D. W. Williamson, Y. Huang, and R. W. Mahley. 2006. Apolipoprotein AV: a potential modulator of plasma triglyceride levels in Turks. J. Lipid Res. 47: 144-153.
24. Lai, C-Q., E-S. Taii, C. E. Tan, J. Cutter, S. K Chew, Y-P. Zhu, X. Adiconis, and J. M. Ordovas. 2003. The apoA-V locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J. Lipid Res. 44: 2365-2373.
25. Lai, C-Q., S. Demissie, L. A. Cupples, Y. Zhu, X. Adiconis, L. D. Parnell, and J. M. Ordovas. 2004. Influence of the apoA-V locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J. Lipid Res. 45: 2096-2105.
26. Qi, L., S. Liu, N. Rifai, D. Hunter, and F. B. Hu. 2007. Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes. Atherosclerosis. 192: 204-210.
27. Wright, W. T., I. S. Young, D. P. Nicholls, C. Patterson, K Lyttle, and C. A. Graham. 2006. SNPs at the ApoA5 gene account for the strong association with hypertriglyceridemia at the ApoA5/A4/C3/ A1 gene locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis. 185: 353-360.
28. Hokanson, J. E., and M. A. Austin. 1996. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based prospective studies. J. Cardiovasc. Risk. 3: 213-219.
29. Zilversmit, D. B. 1979. Atherogenesis: a postprandial phenomenon. Circulation. 60: 473-485.
30. Karpe, F. 1997. Postprandial lipid metabolism in relation to coronary heart disease. Proc. Nutr. Soc. 56: 671-678.
31. Groot, P. H., W. A. van Stiphout, X. H. Krauss, H. Jansen, A. van Tol, E. van Ramshorst, S. Chin-On, A. Hofman, S. R. Cresswell, and L. Havekes. 1991. Postprandial lipoprotein metabolism in normo-lipidemic men with and without coronary artery disease. Arterioscler. Thromb. 11: 653-662.
32. Jang, Y., J. Y. Kim, O. Y. Kim, J. E. Lee, H. Cho, J. M. Ordovas, and J. H. Lee. 2004. The -1131 T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacyl-glycerolemia: elevated small, dense LDL concentrations; and oxidative stress in non-obese Korean men. Am. J. Clin. Nutr. 80:832-840.
33. Kim, J. Y., O. Y. Kim, S. J. Koh, Y. Jang, S. S. Yun, J. M. Ordovas, and J. H. Lee. 2006. Comparison of low-fat and high-fat meal on postprandial lipaemic response in non-obese men according to the - 1131T>C polymorphism of the apolipoprotein A5 (apoA-V) gene (randomized cross-over design). J. Am. Coll. Nutr. 25: 340-347.
34. Martin, S., V. Nicaud, S. E. Humphries, and P. J. Talmud, on behalf of the EARS Group. 2003. Contribution of apoA-V gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim. Biophys. Acta. 1637:217-225.
35. Groenendijk, M., R. M. Cantor, T. W. A. de Bruin, and G. M. Dallinga-Thie. 2001. The apoA1-CIII-apoAIV gene cluster. Atherosclerosis. 157: 1-11.
36. Olivier, M., X. Wang, R. Cole, B. Gau, J. Kim, E. M. Rubin, and L. A. Pennacchio. 2004. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics. 83: 912-923.
37. Talmud, P. J., E. Hawe, S. Martin, M. Olivier, G. J. Miller, E. M. Rubin, L. A. Pennacchio, and S. E. Humphries. 2002. Relative contribution of variation within the apoC3/A4/A5 gene cluster in determining plasma triglyceride. Hum. Mol. Genet. 11: 3039-3046.
38. Mc Namara, J. R., C. Huang, T. Massov, E. T. Leary, G. R. Warnick, H. B. Rubins, S. J. Robins, and E. J. Schaefer. 1994. Modification of the dextran-Mg12 high-density lipoprotein cholesterol precipitation method for use with previously frozen plasma. Clin. Chem. 40: 233-239.
39. Friedewald, W. T., R. J. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low density-lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
40. Griffin, B. A., M. J. Caslake, B. Yip, G. W. Tait, C. J. Packard, and J. Shepherd. 1990. Rapid isolation of low density lipoprotein subfractions from plasma by density gradient ultracentrifugation. Atherosclerosis. 83: 59-67.
41. Frayn, K. N. 1997. Metabolic Regulation: A Human Perspective. Portland Press, Oxford, UK 111-119.
42. Merkel, M., and J. Heeren. 2005. Give me A5 for lipoprotein hydrolysis. J. Clin. Invest. 115: 2494-2496.
43. Beckstead, J. A., M. N. Oda, D. D. O. Martin, T. M. Forte, J. K. Bielicki, T. Berger, R. Luty, C. M. Kay, and R. O. Ryan. 2003. Structure-function studies of human apolipoprotein A-V: regulator of plasma lipid homeostasis. Biochemistry. 42: 9416-9423.
44. Marcais, C., B. Verges, S. Charriere, V. Pruneta, M. Merlin, S. Billon, L. Perrot, J. Drai, A. Sassolas, L. A. Pennacchio, et al. 2005. ApoA5 Q139X truncation predisposes to late-onset hypercholomicronemia due to lipoprotein lipase impairment. J. Clin. Invest. 115: 2862-2869.
45. Jong, M. C., M. H. Hofker, and L. M. Havekes. 1999. Role of the apoCs in lipoprotein metabolism. Arterioscler. Thromb. Vasc. Biol. 25:1097-1099.
46. Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
47. Peacock, R. E., A. Temple, V. Gudnason, M. Rosseneu, and S. E. Humphries. 1997. Variations at the lipoprotein A1-C111 gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Genet. Epidemiol. 14: 265-282.
48. Mahley, R. W., J. Pepin, K. E. Palaoglu, M. J. Malloy, J. P. Kane, and T. P. Bersot. 2000. Low levels of high density lipoproteins in Turks, a population with elevated hepatic lipase. High density lipoprotein characterization and gender-specific effects of apolipoprotein E genotype. J. Lipid Res. 41: 1290-1301.
49. Knopp, R. H. 2002. Risk factors for coronary artery disease in women. Am. J. Cardiol. 89: 28E-35E.
50. Inazu, A., J. Koizumi, and H. Mabuchi. 2000. Cholesterol ester transfer protein and atherosclerosis. Curr. Opin. Lipidol. 11: 389-396.